AU2001294624A1 - Recombinant adenovirus vectors that are replication-competent in tert-expressing cells - Google Patents
Recombinant adenovirus vectors that are replication-competent in tert-expressing cellsInfo
- Publication number
- AU2001294624A1 AU2001294624A1 AU2001294624A AU9462401A AU2001294624A1 AU 2001294624 A1 AU2001294624 A1 AU 2001294624A1 AU 2001294624 A AU2001294624 A AU 2001294624A AU 9462401 A AU9462401 A AU 9462401A AU 2001294624 A1 AU2001294624 A1 AU 2001294624A1
- Authority
- AU
- Australia
- Prior art keywords
- competent
- replication
- tert
- expressing cells
- recombinant adenovirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/761—Adenovirus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23387200P | 2000-09-20 | 2000-09-20 | |
US60/233,872 | 2000-09-20 | ||
US09/956,335 | 2001-09-19 | ||
US09/956,335 US6627190B2 (en) | 1999-07-12 | 2001-09-19 | Recombinant adenovirus vectors that are replication-competent in tert-expressing cells |
PCT/US2001/029550 WO2002024640A2 (en) | 2000-09-20 | 2001-09-20 | Recombinant adenovirus vectors that are replication-competent in tert-expressing cells |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001294624A1 true AU2001294624A1 (en) | 2002-04-02 |
Family
ID=26927320
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001294624A Abandoned AU2001294624A1 (en) | 2000-09-20 | 2001-09-20 | Recombinant adenovirus vectors that are replication-competent in tert-expressing cells |
Country Status (4)
Country | Link |
---|---|
US (1) | US6627190B2 (en) |
EP (1) | EP1326839A2 (en) |
AU (1) | AU2001294624A1 (en) |
WO (1) | WO2002024640A2 (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6610839B1 (en) | 1997-08-14 | 2003-08-26 | Geron Corporation | Promoter for telomerase reverse transcriptase |
US7378244B2 (en) * | 1997-10-01 | 2008-05-27 | Geron Corporation | Telomerase promoters sequences for screening telomerase modulators |
US6900049B2 (en) * | 1998-09-10 | 2005-05-31 | Cell Genesys, Inc. | Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
US7691370B2 (en) * | 1998-10-15 | 2010-04-06 | Canji, Inc. | Selectivity replicating viral vector |
US6627190B2 (en) * | 1999-07-12 | 2003-09-30 | Saint Louis University | Recombinant adenovirus vectors that are replication-competent in tert-expressing cells |
US7589069B1 (en) * | 1999-07-12 | 2009-09-15 | Saint Louis University | Replication-competent anti-cancer vectors |
US20010044431A1 (en) * | 2000-03-21 | 2001-11-22 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
US20030138405A1 (en) * | 2001-04-17 | 2003-07-24 | Juan Fueyo | Conditionally replicative adenovirus to target the Rb and Rb-related pathways |
CN1195056C (en) * | 2001-07-12 | 2005-03-30 | 钱其军 | Recombined virus for specific proliferation and high efficiency expression of anti-cancer gene in tumor cells and its constitution method |
EP1281767A3 (en) | 2001-07-31 | 2003-05-28 | Aladar A. Szalay | Light emitting microorganisms and cells for diagnosis and therapy of tumors |
JP4475561B2 (en) * | 2001-10-11 | 2010-06-09 | メルク・シャープ・エンド・ドーム・コーポレイション | Hepatitis C virus vaccine |
US20060147420A1 (en) | 2004-03-10 | 2006-07-06 | Juan Fueyo | Oncolytic adenovirus armed with therapeutic genes |
EP1504016A4 (en) * | 2002-05-08 | 2006-11-22 | Intronn Inc | Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses |
EP1369491A1 (en) * | 2002-06-05 | 2003-12-10 | Aladar A. Szalay | Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
US20030228261A1 (en) * | 2002-06-05 | 2003-12-11 | Aladar Szalay | Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
US20040213764A1 (en) * | 2003-03-28 | 2004-10-28 | William Wold | Adenovirus replication-competent vectors expressing trail |
US20050136035A1 (en) * | 2003-06-03 | 2005-06-23 | Derek Ko | Cell specific replication-competent viral vectors comprising a self processing peptide cleavage site |
EP1636360A4 (en) * | 2003-06-03 | 2006-11-08 | Cell Genesys Inc | Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site |
US7598077B2 (en) * | 2003-06-05 | 2009-10-06 | The United States Of America As Represented By The Department Of Health And Human Services | Compositions and methods for enhancing differential expression |
US7588767B2 (en) | 2003-06-18 | 2009-09-15 | Genelux Corporation | Microorganisms for therapy |
US7815902B2 (en) * | 2003-07-09 | 2010-10-19 | Henry Ford Health System | Methods and compositions for cancer therapy using a novel adenovirus |
DE602004012269T2 (en) * | 2003-07-11 | 2009-04-30 | Theravance, Inc., South San Francisco | CROSS-LINKED GLYCOPEPTIDE-CEPHALOSPORIN ANTIBIOTICS |
US20080292592A1 (en) * | 2004-04-30 | 2008-11-27 | Sunil Chada | Oncolytic Adenovirus Armed with Therapeutic Genes |
CN100361710C (en) * | 2004-06-07 | 2008-01-16 | 成都康弘生物科技有限公司 | Construction and application of oncolytic adenovirus recombinant of tumor cell specifically expressing immunoregulation factor GM-CSF |
KR100792183B1 (en) * | 2006-05-29 | 2008-01-07 | 울산대학교 산학협력단 | Synthetic Human Telomerase Reverse Transcriptase Promoter Enhancing Gene Expression |
EP2415783B1 (en) * | 2006-10-16 | 2016-12-14 | Genelux Corporation | Modified vaccinia virus strains for use in a diagnostic and therapeutic method |
DK2245464T3 (en) | 2008-01-25 | 2017-02-20 | Multivir Inc | P53 BIOMARKETS |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5801029A (en) | 1993-02-16 | 1998-09-01 | Onyx Pharmaceuticals, Inc. | Cytopathic viruses for therapy and prophylaxis of neoplasia |
US5851806A (en) * | 1994-06-10 | 1998-12-22 | Genvec, Inc. | Complementary adenoviral systems and cell lines |
US6197293B1 (en) | 1997-03-03 | 2001-03-06 | Calydon, Inc. | Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
US6254862B1 (en) | 1997-03-03 | 2001-07-03 | Calydon, Inc. | Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
US6627190B2 (en) * | 1999-07-12 | 2003-09-30 | Saint Louis University | Recombinant adenovirus vectors that are replication-competent in tert-expressing cells |
-
2001
- 2001-09-19 US US09/956,335 patent/US6627190B2/en not_active Expired - Lifetime
- 2001-09-20 EP EP01975285A patent/EP1326839A2/en not_active Withdrawn
- 2001-09-20 AU AU2001294624A patent/AU2001294624A1/en not_active Abandoned
- 2001-09-20 WO PCT/US2001/029550 patent/WO2002024640A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2002024640A2 (en) | 2002-03-28 |
US6627190B2 (en) | 2003-09-30 |
EP1326839A2 (en) | 2003-07-16 |
WO2002024640A3 (en) | 2003-03-27 |
US20020028785A1 (en) | 2002-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001294624A1 (en) | Recombinant adenovirus vectors that are replication-competent in tert-expressing cells | |
AU1340000A (en) | Novel adenoviral vector and methods for making and using the same | |
AU3635899A (en) | Recombinant adenovirus gene transfer vector | |
IL161584A (en) | Recombinant adenovirus host cells and compositions containing same and uses thereof | |
AU4255397A (en) | Chimpanzee adenovirus vectors | |
AU2002327380A1 (en) | Cells and methods for propagating adenoviral vectors | |
AU5882801A (en) | Novel recombinant adenovirus vector with relieved side effects | |
AU2035601A (en) | Load cell | |
AU7435500A (en) | Adenoviral vectors | |
AUPQ520600A0 (en) | Improvements in electrolysis cells | |
AU2001229728A1 (en) | Replication deficient adenovirus vectors | |
AU4942499A (en) | Load cell | |
GB2345402B (en) | Improvements in loudspeakers | |
AU2001281464A1 (en) | Recombinant proteins containing repeating units | |
AU2145300A (en) | Adenoviral vectors | |
AU1092500A (en) | Recombinant e1a deleted adenoviral vectors | |
AU1343300A (en) | Cell surface glycoproteins | |
AU2350997A (en) | Novel adenoviral vector for transferring human genes in vivo | |
HUP0203801A3 (en) | Recombinant adenoviruses preparation and adenovirus banks | |
AU2001237215A1 (en) | Genetically modified fibroblast cell | |
AU2002215747A1 (en) | Pixel cell architecture | |
AU5805798A (en) | Recombinant adenoviral vector expressing antigens associated with colorectal tumors | |
AU5931600A (en) | Lcat recombinant cell line compositions and methods | |
IL128742A0 (en) | Recombinant adenovirus vector | |
AU4070499A (en) | Adenoviral vectors with tandem fiber proteins |